CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults.
about
Functionally defective or altered CYP3A4 and CYP3A5 single nucleotide polymorphisms and their detection with genotyping testsPrevalence of common disease-associated variants in Asian Indians.Measurement and compartmental modeling of the effect of CYP3A5 gene variation on systemic and intrarenal tacrolimus disposition.CYP3A variation and the evolution of salt-sensitivity variantsEffect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part II.Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT).Resistant hypertension workup and approach to treatmentMolecular diversity and population structure at the Cytochrome P450 3A5 gene in Africa.Prevalence and risk factors for resistant hypertension among hypertensive patients from a developing country.Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolismTop Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine.Significance of the minor cytochrome P450 3A isoforms.Pharmacokinetics of tacrolimus during pregnancyProximal tubular function and salt sensitivity.Clinical implications of CYP3A polymorphisms.Association between urinary 6β-hydroxycortisol/cortisol ratio and CYP3A5 genotypes in a normotensive population.CYP3A5 gene variation influences cyclosporine A metabolite formation and renal cyclosporine disposition.The pharmacogenetics research network: from SNP discovery to clinical drug response.Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update.PharmGKB summary: very important pharmacogene information for CYP3A5.Pharmacogenetics of immunosuppressive drugs: prospect of individual therapy for transplant patients.Prediction of CYP3A4 enzyme activity using haplotype tag SNPs in African Americans.CYP3A5 and ABCB1 genes and hypertension.Molecular population genetics of human CYP3A locus: signatures of positive selection and implications for evolutionary environmental medicine.Ambient tonicity and intestinal cytochrome CYP3A.Gene-environment interactions of selected pharmacogenes in arterial hypertension.CYP3A5 polymorphism, amlodipine and hypertension.Calcineurin inhibitors and hypertension: a role for pharmacogenetics?Sodium, blood pressure, and ethnicity: what have we learned?Effects of CYP3A5 polymorphisms on tacrolimus pharmacokinetics in pediatric kidney transplantation: a systematic review and meta-analysis of observational studies.Ethnic differences in the distribution of CYP3A5 gene polymorphisms.The Uromodulin Gene Locus Shows Evidence of Pathogen Adaptation through Human Evolution.Hypertension-susceptibility gene prevalence in the Pacific Islands and associations with hypertension in Melanesia.The association among cytochrome P450 3A, progesterone receptor polymorphisms, plasma 17-alpha hydroxyprogesterone caproate concentrations, and spontaneous preterm birth.Association of the CYP3A5 polymorphism (6986G>A) with blood pressure and hypertension.CYP3A5 as a candidate gene for hypertension: no support from an unselected indigenous West African population.Association of CYP3A5 polymorphisms with hypertension and antihypertensive response to verapamil.CYP3A5 polymorphism and sensitivity of blood pressure to dietary salt in Japanese men.Differential Regulation of CYP3A4 and CYP3A5 and its Implication in Drug Discovery.Polymorphisms in CYP1A1 and CYP3A5 Genes Contribute to the Variability in Granisetron Clearance and Exposure in Pregnant Women with Nausea and Vomiting.
P2860
Q28260518-F0C2A629-C456-42B1-AFAE-784F7D1097A7Q33318138-3812025F-ED9A-45C2-ADB8-8E1653EB7D3DQ33683838-36B9882C-4C0C-4208-A982-424577F283A2Q33910537-0F414397-01B5-48EF-8FD6-44ED19A11DF1Q34102899-E3CA4003-C704-43FD-B776-92B7B4E3D6A0Q34325249-730E8954-CEBC-46E1-8312-FAF338F4F6B0Q34460704-61172111-09C1-4EFB-BA2F-A273AA7233CEQ34704763-71273E1D-3710-43BE-B1A6-CF33765A68DAQ34992852-A41AB33A-CD74-442E-90C0-7D27ACCB1B08Q36099442-5EF8F89E-A9E0-4F10-AB04-448EEA4A9666Q36285918-E2F68741-FBF4-4702-AD2D-003139AD704BQ36375323-C5E54D4F-1AFC-4EF3-A999-67E9FC54D081Q36400412-8317574F-C934-404C-9110-B09C65928DEBQ36442571-CD8F4124-32FD-476D-ADE9-237B7D965E64Q36546247-FE200544-C635-4687-A17D-A1236A048035Q36603665-32253976-3D8E-4830-A896-71F0699C2483Q36704223-E4DA23EC-BCB6-40C8-B59B-34EEE41E0A3CQ36752662-8D9D7DC2-0D81-420D-8976-A46D14357E2FQ37074093-1802CFC8-2954-4FFF-AEDE-04B99BFCB131Q37081741-1231F4DD-BE83-4B24-AC67-6FCBE1394BABQ37157896-FCA08147-2A43-4B4E-89F6-3DACE5B3ED45Q37369341-CB34A6BA-E1DD-46E0-9A17-BB196F3B870CQ37416133-7D730694-0CEC-411A-A873-24E33A3FA3CDQ37465914-CEC02CC3-AD2F-4189-90B4-3C70EF584C33Q37725997-551661AE-4DE8-4EF0-8CEC-76A0F37219DAQ38066959-7A323EF9-D816-4EB4-958B-C646C64930D5Q38122295-09359F99-809A-4354-8A04-862054098043Q38241677-049A79BF-7C89-4728-9D1F-273122E9DBB4Q39025145-23C0BAA3-7F85-4A99-A08F-613EBCC867A8Q39328270-59EF1C33-C646-4F56-B998-C4FE4D5954F9Q39374368-3152ABE6-DCC7-44E6-92A1-7354D647FB1CQ39930066-4B22C30B-A80B-48B9-9077-17741BF7A2F1Q44937515-C55BD051-BE81-46CA-BC77-917E750A2AC0Q46304188-0600C1E4-1FB6-43A2-A742-7CD375A7FCF0Q46480439-5D9F45A7-FC05-4B7A-A259-C213B14A154FQ46683443-80B789B6-A71D-4F14-ADEC-C7A20DB8FA77Q46796622-CB98944D-ED4E-4301-9045-41B6DDF41994Q47436945-9B59D277-5848-4792-8708-D3AADE8D37DFQ50179674-1AEF5E86-08D4-43DC-8FE6-FEA7095E98ABQ51347270-37F33455-A3E4-47F1-A7EA-B2A341418CBD
P2860
CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults.
@en
CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults.
@nl
type
label
CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults.
@en
CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults.
@nl
prefLabel
CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults.
@en
CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults.
@nl
P2093
P2860
P1476
CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults.
@en
P2093
Amy L S Dowling
Erin G Schuetz
Jatinder K Lamba
Kenneth E Thummel
Paul B Watkins
Paul W Stewart
Raymond C Givens
Yvonne S Lin
P2860
P304
P356
10.1152/JAPPLPHYSIOL.00322.2003
P407
P577
2003-05-16T00:00:00Z